Alzheimer's disease | Alzheimers symptoms| Alzheimers Conferences 2021 | Alzheimers Congress | Dementia Covid-19 Meetings | Top Alzheimers Conferences| Neurology and Covid-19 Conferences | Neuroscience Conference | USA | Europe | Middle East | Asia Pacific

Theme: Innovative approaches to defeat Alzheimers Disease and Dementia

Alzheimers Congress 2021

Renowned Speakers

Yuqiu Zheng
Sun Yat-sen Memorial Hospital,
China

Reshma Merchant
National University Hospital,
Singapore

Philip Choo
National Healthcare Group,
Singapore

Jun Liu
Sun Yat-sen University,
China

Alzheimers Congress 2021

Join us for 12th World Congress on Alzheimers Disease & Dementia

Innovative approaches to defeat Alzheimers Disease and Dementia

We welcome all the participants from all over the world to attend ‘ 12th World Congress on Alzheimers Disease & Dementia is scheduled for july 13-14,2021.in our Webinar Meet which will be through onstream and partcipants like keynote, special sessions, poster, oral presentations will deliver their talk on-stream.

Can we cure Dementia?

Discovering the friend or family member has Alzheimer's or other types of dementia is Scary. One of the primary inquiry is individuals inquires as to whether there is a cure or an approach to recouping? Not all loss of memory is recognized with Alzheimer's or dementia. There are different reasons you may encounter memory issues including thyroid issues, stretch and vitamin insufficiencies or certain medicines.

There is currently no "cure" for dementia. Dementia is triggered by different diseases, that’s why it is impossible that there will be a solitary cure for dementia.

Dementia, as well as Alzheimer’s disease, is one of the biggest global public health challenges facing our generation. Worldwide, at least 44 million people are living with insanity this range is anticipated to double by 2030 and quite triple by 2050 to 115 million. Much of the increase will be in developing countries like Western Europe and North America. Already 62% of individuals with Dementia board developing countries. Today, over 35 million individuals worldwide presently abide the condition. No medicines out there to slow or stop the cerebrum damage brought about by Alzheimer's malady, a few prescriptions can briefly help improve the side effects of dementia for certain individuals. In 20 Years, it is estimated that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year. Globally, dementia cost $600 billion a year.

Track 1:Dementia

Dementia is not a specific disorder. It is an overall term that describes a wide variety of signs associated with a decline in memory or other thinking talents extreme enough to lessen a person's ability to perform regular activities. Vascular dementia, which takes place after a stroke, is the second most not unusual dementia type. But there are numerous other conditions that may cause signs and symptoms of dementia, which include some which might be reversible, such as thyroid issues and vitamin deficiencies. Dementia is a syndrome that involves intense loss of cognitive talents due to ailment or injury. Dementia as a result of worrying mind harm is often static, whereas dementia due to neurodegenerative disorders, inclusive of Alzheimer's disease, is commonly revolutionary and can sooner or later be fatal. Dementia can be grouped based totally on the part of brain being affected. it is miles roughly true that the earliest signs in "cortical" dementia include difficulty with high-level behaviour’s which includes reminiscence, language, problem-solving and reasoning; these features generally tend to be less impaired in "subcortical" dementia. Cortical dementia occurs due to damage within the cerebral cortex, the outer layer of the mind. They play an important role in reminiscence and language.

Dementia Causes, Concerns and Preventions
Dementia Research
Diagnosing Dementia
Dementia during Aging

Track 2:Geriatrics dementia and Alzheimer’s diseas e

Dementia Geriatrics or Geriatric medicine is most likely a peculiarity that spotlights on social inclusion of more master people. It intends to push prosperity by methods for thwarting and treating contaminations and insufficiencies in increasingly set up adults. There is no set age at that sufferers are furthermore under the consideration of an expert or geriatric MD, a MD United Nations association causes a to announce to notoriety of the consideration of increasingly prepared people. Or on the other hand possibly, this call is prepared by utilizing the character patient's wants and right now openness of an ace. It is basic to look the capability among gerontology, the consideration of developed people, and geriatrics, a great method to be that the exploration of the developing methodology itself.

Scholarly difficulty square degree a classification of mental state issue that mainly influence learning, memory, wisdom, and drawback affirmation, and encapsulate vitality blackout, dementia, and craziness. While disquiet trouble, tendency trouble, and insane trouble can even influence scholarly issue and memory works, the DSM-IV-TR would not think about these psychological component troubles, considering that loss of highbrow limit is not the fundamental (causal) feature impact. Causes trade among the various sorts of messes yet most extreme consolidate harm to the memory components of the cerebrum. Meds depend on however the unrest is caused. Pharmaceutical and medications square measure the important typical meds at the indistinguishable time, for a couple of types of disarranges like amnesia, medications will smother the symptoms however there is by and through no fix.

This session contains Neurodegenerative diseases, Geriatric debacle arrangement, Geriatric diagnostics, Geriatric nervous system science, Geriatric oncology, Geriatric psychiatry or psychogeriatric, Geriatric pharmacotherapy, Alcohol impulse and passionate prosperity, Nutritional need, Preventions: Mental movement and sound way of life.

Biomarkers for dementia
Drug development in dementia
Animal models in dementia
Alzheimer disease and cellular mechanisms

Track 3: Alzheimer’s Diseases

Alzheimer's disease is irreversible and decimates cerebrum cells, making thinking ability and reminiscence weaken. Alzheimer's contamination is a dynamic, degenerative mind disorder and the maximum widely identified type of dementia, a meeting of brain issues that influence a man's reminiscence, thinking about and capability to attach socially. Dementia and Alzheimer's contamination is not the same. Dementia is a standard term used to depict symptoms that effect reminiscence, execution of each day exercises, and correspondence capacities. Alzheimer's contamination is the most widely diagnosed sort of dementia. Alzheimer's illness is not a standard piece of maturing. We are main exploration into a part of aggravation in Alzheimer's illness to discover ability focuses for remedial mediation. The Dominantly Inherited Alzheimer Network is the principle purpose to find out biomarkers for Alzheimer's Diseases that are perceptible a while before the underlying clinical aspect effects. Members enjoy cerebrum assessments and clinical evaluations and deliver blood and spinal liquid to explore. Presently making use of hereditary linkage approaches to cope with endeavor to distinguish these modifier qualities, which may deliver beneficial focuses to the remedy of Alzheimer's illness.

Amyloid Hypothesis
Down Syndrome
Animal models in dementia
Alzheimer disease and cellular mechanisms

Track 4: Dementia Care Management

Caring for a person with dementia influences distinctive people in diverse ways. In any case, caring can also be both physically and rationally debilitating. It affects all factors of your life and may have an impact on you to feel separated, driven and at instances even discouraged. You may additionally have your own physical and psychological wellbeing needs, which you and others may additionally neglect while you are tending to some other person. There are severe high-quality things about caring. These incorporate adapting new aptitudes, expanding on existing ones, reinforcing connections, having a feeling of delight in what you are doing, and assisting somebody who is vital to you. Dementia cares the executives is a model of network orientated consideration, characterized as an unpredictable intercession planning to offer ideal remedy and care to patients with dementia and bolster parental figures utilizing a PC helped appraisal determining a customized cluster of mediation modules and resulting fulfilment checking.

Dementia Care Practice
Effectiveness and safety of dementia care management
Therapeutic interventions in dementia

Track 5: Parkinson Diseases

Parkinson's Diseases (PD) is a never-ending and dynamic neurological problem that influence engine work, inflicting bradykinesia, postural unsteadiness, inflexibility, and tremor very still. Side effects develop progressively, making start finding troublesome. PD likewise has some non-engine highlights, inclusive of psychological well-being issues, rest unsettling impacts and autonomic aggravations. At introduce, there may be no treatment for PD. The remedy is, subsequently, long past from treating side consequences. There is proper now two fundamental ways to address more suitable dopaminergic action in the mind: increasing dopamine emission with exogenous operators and focusing on associated neurotransmission pathways. Levodopa is the regular metabolic antecedent of dopamine and is profoundly a success for treating PD indications. Side outcomes of Parkinson's Diseases are commonly overseen utilizing a particular dopamine receptor agonist. While these medicinal drugs are treasured in starting time Parkinson's, they tend to lose viability in later illness stages.

Neuro Psychiatry of Parkinson Disease
Clinical Diagnostics of Parkinson Disease
Neuropathophysiological Condition

Track 6: Clinical features and Physiotherapy for dementia

The point of a decent arrangement of the examination diversion in dementia is to expand mediations for 'cure' or even 'fix'. The old-style seat to bedside worldview has been baffling in dementia. There is a long posting of putative dementia treatment mixes with positive pre-medicinal and early-stage preliminary realities which have been impartial or even conceivably hurtful while surveyed in fragment III investigations. Lewy body dementia is a typical anyway frequently under analyzed intention of dementia regularly inadmissible for the more familiar substance of Alzheimer malady. Clinically the qualification is significant, in light of the fact that it might have significant ramifications for the executives. The anticipation of Lewy body dementia has basic ramifications. It is related with an over-the-top pervasiveness of neuroleptic affectability, requiring fabulous alert inside the utilization of those basic antipsychotic specialists. Early investigations demonstrate cholinesterase inhibitors can be advantageous for treating the mental trips and conduct unsettling influences that torment those patients and can likewise improve perception.

Immunotherapy
Frontotemporal dementia
Clinical psychology

Track 7: Neurological Diseases

Neurological disorders are maladies of the focal and fringe sensory machine. At the end of the day, spinal rope, cranial nerves, fringe nerves, nerve roots, autonomic sensory device, and neuromuscular intersection. These disarranges comprise epilepsy, Alzheimer contamination and one of a kind dementias, cerebrovascular sicknesses such as stroke, headache and different migraine issue, numerous sclerosis, Parkinson's infection, neuroinfectious, mind tumors, lousy scatters of the sensory system because of head injury, and neurological issue because of hunger. Neurological manifestations may additionally happen because of the contamination itself or due to a safe reaction. Countless individuals international are influenced via neurological disarranges. Alzheimer's sickness is the maximum widely identified purpose for dementia and might add to 60– 70% of cases.

Chronic Neurological Diseases
Epilepsy and Seizures
Cerebral Aneurysm
Neurocutaneous Syndromes

Track 8: Alzheimer’s disease Pathogenesis

Alzheimer's infection is an advanced dementia with absence of neurons and the nearness of leader tiny neuropath logical trademarks: extracellular amyloid plaques and intracellular neurofibrillary tangles. Early starting AD, an unusual familial shape, is incited because of exchange of one out of 3 qualities. Sporadic shape happens normally after age of sixty-five and bills for maximum cases; it best plausible influences from a mix of hereditary and effect of environment. Affirmed risk factors for sporadic AD are age and the nearness of the E4 allele of (Apo lipoprotein E) Amyloid plaques incorporate explicitly of the neurotoxic peptide amyloid (Aβ, A beta), cut consecutively from a greater forerunner protein (APP) thru two compounds: β-secretes (otherwise known as BACE1) and γ-secretes (including four proteins, presently is one in the entirety about). Neurofibrillary tangles contain mainly of the protein tau which ties with microtubules, which encouraging the neuronal transportation framework. Tau uncoupling from microtubules and collection into tangles represses delivery and results in dismantling of microtubule. Phosphorylation of tau may also have a crucial capability on this. Specific weakness of neuronal structures which incorporates the cholinergic, serotonergic, and noradrenergic and glutamatergic frameworks shape the cause of modern discerning pharmacological cure.

Stem cells and Cell death
Tau Pathology of Alzheimer’s Disease
Cellular signaling, kinases, phosphatases, calcium.
Pathogenesis of Alzheimer’s Disease
Cerebral Amyloid Antipathy

Track 9: Alzheimer Disease and Cellular Mechanisms

Most continuous endeavors to battle Alzheimer Disease are targeted around treating its clinical symptoms, however the neuropathology modifications fundamental show up decades sooner and flip out to be essentially irreversible when the illness achieves its clinical stages. This calls for treating at preclinical stages, which requires a superior comprehension of the important units prompting Alzheimer Disease pathology. Alzheimer's contamination is a complex hereditary problem that is the main supply of dementia in the elderly. Atomic affirmation raised the presumptions that trafficking of the amyloid precursor protein is under control of insulin flagging. Most progressing endeavors to battle Alzheimer infection are focused round treating its medical facet effects, however the neuropathology modifications fundamental display up decades sooner and turn out to be essentially irreversible whilst the disease achieves its scientific stages.

Among those cerebrum affronts which bring about dementia, in more seasoned individuals, Alzheimer's illness is the most widely diagnosed. The infection is identified by a few synapse changes which incorporate synapse misfortune, thoughts shrinkage, a protein trade inner neuron referred to as neurofibrillary degeneration, and an unconventional degenerative difference in neuron terminals wherein another type of fibrillary material called amyloid may accumulate within the extracellular spaces.

Neurofibrillary Degeneration
Nervous System Disease
Medial Temporal Lobe
Fixing Genetic risk for Alzheimer’s

Track 10: Medical Biotechnology and Alzheimer’s disease

Alzheimer's disease as a dynamic and deadly neurodegenerative sickness speaks to an immense ignored requirement for treatment. The low viability of current remedy techniques is not just due to low medicinal drug depth yet in addition due to the nearness of various hindrances in the conveyance courses. One of the fundamental limitations is the blood mind boundary. The expanding predominance of Alzheimer's Diseases and the low viability of ebb and flow treatments have elevated the measure of studies on unwinding of illness pathways and development of treatment techniques. One of the captivating regions for the remaining challenge is biotechnology and their applications. Nanotechnology is a standout amongst the most critical subject in biotechnology and has a noteworthy part inside the development of novel remedial modalities with accelerated adequacy. In the nanotechnology subject, materials are designed with utilitarian association at the Nano scale. Every one of the materials is applied for affiliation and incitement of natural frameworks on the atomic stage to instigate physiological reactions. One of the primary troubles regarding the remedy of neurodegenerative sicknesses are identified with medicates conveyance.

Alzheimer disease drug discovery
Molecular and Cellular Basis of Neurodegeneration
Vaccine against Alzheimer’s disease
Biology of Ageing

Dementia is a general term that describes a group of symptoms-such as decline in mental capability, judgment, language, complex motor skills, and other intellectual function-caused by brain damage from cerebrovascular, death of the brain's nerve cells, or neurons. Dementia may be caused by several factors, such as drug abuse, alcoholism, brain injury, side effects to certain medications, thyroid function abnormalities, vitamin B12 deficiency, etc.

Dementia including Alzheimer’s disease, is one of the biggest global public health challenges and disorder facing our generation. Vascular dementia is the second most common cause of dementia caused by brain damage.

From recent reports, markets for Alzheimer’s treatments exist with the development of some therapeutic methods and the increasing incidence of the disease. The increasing incidence of Alzheimer’s disease is mainly attributed to the growing number of people over the age of 65. Although some instances of young onset have occurred, this is defined as Alzheimer’s symptoms in people under the age of 65. Alzheimer’s disease is estimated to affect up to 6% of the population over 65.

The global report for Alzheimer’s disease reached $10.2 billion in 2012 and still increasing. The global market for AD therapeutics and diagnostics by region should reach over $6.2 billion by 2020 from $4.4 billion in 2015, at a compound annual growth rate (CAGR) of 7.1% from 2015 to 2020.

Analyses of global market trends, with data from 2014, 2015 and 2016, and projections of CAGRs through 2021 has covered different types of tests, including esoteric, public health, anatomic technology, genomic testing, mass spectrophotometry, and other new technologies.

From an overview of the global market for laboratory-developed testing found that laboratory tests reached nearly $9.7 billion in 2015. This market is expected to increase from nearly $11.0 billion in 2016 to $14.9 billion in 2021 at a compound annual growth rate (CAGR) of 6.3% for 2016-2021.

DEMENTIA 2020

DEMENTIA 2020 Webinar

We delightedly thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, for making this conference successful!

Conference series LLC ltd successfully anchored its leading "16thInternational Conference on Dementia and Alzheimer Disease" slated on July 27-28, 2020 Webinar.

Dementia conference 2021 is distinguished with the attendance of Editorial Board Members of supported Journals such as Journal of Neurology and Neurophysiology, Journal of neurology & Neuroscience, Journal of Alzheimer’s Disease & Parkinsonism, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference rewarding and fecund.

Our 16th International Conference on Dementia and Alzheimer Disease was based on the theme Update your skills, enhance your knowledge base, and broaden your horizons during Covid-19” which has encrusted the below scientific sessions:

Dementia
Symptoms and diagnosis of dementia
Dementia care practice & awareness
Alzheimer’s disease diagnosis and symptoms
Alzheimer’s imaging and clinical trials
Alzheimer’s pathophysiology
Parkinson’s disease
Dementia with Lewy bodies
Frontotemporal dementia
Wernicke-Korsakoff syndrome
Geriatrics care practice and awareness neuroscience
Vascular dementia
Amyloid protein in dementia
Neurology and neurosurgery
Therapeutic targets & mechanisms for treatment
Animal models & translational medicine

The conference was initiated with a warm welcome note and the book launch from honorable guests and the keynote forum. The proceedings went through interactive sessions and panel discussions.

Immense support was extended by the keynote lectures mentioned below:

Steven Benevity Partner at Davis, Saperstein & Salomon Personal Injury Law Firm NJ & NY USA
Glenda MacQueen University of Calgary Canada
Kirk Brower University of Michigan East Medical Campus USA
T. Chris Gambling University of Kansas USA
Alan M. Palmer Tenebrescence Ltd, UK
Chetan P. V. Rao Program Director Baylor College of Medicine USA
Brent Harris Georgetown University Medical Center USA
Conference Series LLC ltd wishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, Valuable speakers, Poster presenters, students, delegates to make this event a huge success.

We welcome you to our upcoming “12th World Congress on Alzheimer’s Disease & Dementia” during July 13-14, 2021 Webinar.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	July 13-14, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Media Partners

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

12^thWorld Congress on Alzheimers Disease & Dementia July 13-14, 2021 Bangkok, Thailand

Recommended Global Neuroscience Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com